Rusco Pharma Private Limited

Pharmaceutical company specializing in production, trade, and distribution of drugs and medicines.

1994 | Mumbai, Maharashtra (India) | Converted to LLP
Last Updated: April 25, 2024

Rusco Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 30 Year, 5 Months
  • Last Filing with ROC 31 Mar 2016
  • Satisfied Charges ₹ 7.00 Cr
  • Revenue Growth 2.23%
  • Profit Growth -28.15%
  • Ebitda -1459.56%
  • Net Worth 11.99%
  • Total Assets 14.45%

About Rusco Pharma

Rusco Pharma Private Limited (RPPL) is Converted To Llp company established on 16 Aug 1994 with its office registered at Mumbai, Maharashtra, India and has been running since 30 Year, 5 Months with a paid up capital of 0.10 M. According to MCA records, 0 Directors are linked to this company as of 25 Apr 2024.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230MH1994PTC080348

  • Company No.

    080348

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 Aug 1994

  • Date of AGM

    27 Sep 2016

  • Date of Balance Sheet

    31 Mar 2016

  • Listing Status

    Unlisted

  • ROC Code

    Roc-Mumbai

Industry

Financial Services

Who are the key members and board of directors at Rusco Pharma?

Board Members

People

No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.

Financial Performance of Rusco Pharma.

Rusco Pharma Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 2.23% increase. The company also saw a substantial fall in profitability, with a 28.15% decrease in profit. The company's net worth Soared by an impressive increase of 11.99%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
2.23%
Revenue from Operations
Total Assets
14.45%
Profit or Loss
-28.15%
Net Worth
11.99%
EBITDA
-1459.56%

What is the Ownership and Shareholding Structure of Rusco Pharma?

In 2016, Rusco Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹70.00 M

Charges Breakdown by Lending Institutions

  • Icici Bank Ltd : 7.00 Cr

Latest Charge Details

Date Lender Amount Status
12 Nov 2013 Icici Bank Ltd ₹7.00 Cr Satisfied

How Many Employees Work at Rusco Pharma?

Unlock and access historical data on people associated with Rusco Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rusco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rusco Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rusco Pharma

Recent activity within the organization

  • Charges

    A charge registered on 12 Nov 2013 via Charge ID 10461236 with Icici Bank Ltd was fully satisfied on 27 Jan 2017.

    27 Jan 2017

  • Annual General Meeting

    Rusco Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2016 as per latest MCA records.

    27 Sep 2016

  • Balance Sheet

    Rusco Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with RoC-Mumbai.

    31 Mar 2016

  • Charges

    A charge with Icici Bank Ltd of Rs. 70.00 M registered on 12 Nov 2013 with Charge ID 10461236 was modified on 25 Dec 2013.

    25 Dec 2013

  • Charges

    A charge with Icici Bank Ltd amounted to Rs. 70.00 M with Charge ID 10461236 was registered on 12 Nov 2013.

    12 Nov 2013

  • Company Incorporation

    Rusco Pharma Private Limited was registered on 16 Aug 1994 with RoC-Mumbai & aged 30 years 5 months as per MCA records.

    16 Aug 1994

Frequently asked questions

  • Rusco Pharma Private Limited was incorporated on 16 Aug 1994.

  • The authorized share capital of Rusco Pharma Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.

  • As per Ministry of Corporate Affairs (Mca), the registered address of Rusco Pharma Private Limited is Ground Floor Raghuvanshi Mansiraghuvanshi Mills, Compound 9-11 Senapati Bapat Marg Lower, Parel Mumbai, Maharashtra, India, 400013.

  • The corporate identification number (CIN) of Rusco Pharma Private Limited is U24230MH1994PTC080348 and the company number is 080348 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2016, the revenue trend for Rusco Pharma Private Limited has risen by 2.23%.

  • The financial reports for the fiscal year 2016 indicates that The net worth of Rusco Pharma Private Limited has experienced an upsurge of 11.99%.

  • The most recent Balance Sheet for Rusco Pharma Private Limited was filed with the ROC on 31 Mar 2016.

People also Viewed

Similar Companies Based on Real Estate Financing